Mont Albert, Australia

Nicos Anthony Nicola

USPTO Granted Patents = 23 


Average Co-Inventor Count = 7.0

ph-index = 6

Forward Citations = 115(Granted Patents)


Location History:

  • Regent, AU (1993 - 1995)
  • Victoria, AU (1997 - 1998)
  • Melbourne, AU (2000)
  • Mount Albert, AU (2002)
  • Mont Albert, AU (2001 - 2012)

Company Filing History:


Years Active: 1993-2012

Loading Chart...
Loading Chart...
23 patents (USPTO):

Title: Nicos Anthony Nicola: Innovator in Antibody Research

Introduction

Nicos Anthony Nicola, a distinguished inventor based in Mont Albert, Australia, holds an impressive portfolio of 23 patents. His groundbreaking work primarily focuses on monoclonal antibodies, particularly in the field of immunology, targeting specific receptors that play crucial roles in various diseases and conditions.

Latest Patents

Among Nicola's latest patents is a monoclonal antibody designed to bind to the interleukin-13 receptor alpha 1 (IL-13Ralpha1). This innovative antibody antagonizes IL-13 receptor-mediated signaling, effectively modulating the pathways associated with IL-13 and IL-4. The invention includes novel humanized antibodies, which are instrumental in treating or preventing diseases related to these interleukins. Furthermore, his patent encompasses a method for screening modulators of IL-13Ralpha1/ligand interactions, offering a valuable tool for future research in therapeutic developments.

Career Highlights

Nicola has made significant strides in his career, contributing to reputable organizations such as Amrad Corporation Limited and the Walter and Eliza Hall Institute of Medical Research. His work has not only advanced scientific understanding in immunology but has also paved the way for innovative treatment options for various diseases.

Collaborations

Throughout his career, Nicola has collaborated with eminent scientists like Douglas James Hilton and Donald Metcalf. These partnerships have fostered a rich environment for innovation, leading to more impactful discoveries in the field of antibody therapeutics.

Conclusion

With an impressive number of patents and a commitment to advancing medical science, Nicos Anthony Nicola exemplifies the spirit of innovation in biotechnology. His contributions, particularly in the development of monoclonal antibodies, showcase his dedication to addressing complex medical challenges and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…